How to Orchestrate Cell & Gene Therapy Supply Chains

About a year and a half ago, we were asked by a client in the US to help them implement capacity planning & detailed scheduling for manufacturing and quality operations in a CAR-T cell & gene therapy production plant.

What are the insights that we have gained since then? And what have we discovered as game-changing elements in the end-to-end supply chain orchestration? You will discover it in Geert’s presentation.

Key takeaways

1. In this new market, demand is exploding but supply chain is immature
2. There's a mind shift towards a new kind of supply chain, with a lot of moving parts
3. Need to be extremely agile and be able to react in real-time to volatilities in the supply chain